Dec. 18, 2025—Roche launched Cobas 6800/8800 systems version 2.0 and software version 2.0.1, following FDA 510(k) clearance earlier this year. The update enhances throughput and run flexibility, enables sample prioritization, and is available as an upgrade to existing systems.
“This update is significant because it not only allows for new innovation in PCR-testing technology and more choices in omni-channel testing, but it also addresses some key improvements that customers have told us are high priorities for them,” Brad Moore, president and CEO of Roche Diagnostics North America, said in a press release. “All of these updates and improvements can be made to existing 6800/8800 systems through the software upgrade, providing higher throughput to laboratories with the same footprint and delivering more flexibility to physicians and patients.”
New features include an increase in unique assays per run (from three to six) and the flexibility to run up to six assays per sample. Laboratory-developed tests and in vitro diagnostic assays can run simultaneously. The option for a second analytic unit on Cobas 6800 boosts throughput up to 2,112 tests per day.